Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy.

Freddy CalderaStacey RolakFrancis A FarrayeBrian M NecelaDavitte CogenEmily E ZonaTrevor L SchellOscar Ramirez RamirezMazen AlmasryKelly ChunMary S HayneyKeith L Knutson

Published in: Clinical and translational gastroenterology (2024)

A third dose of a COVID-19 vaccine boosts CMIR, and the response is sustained in patients with IBD.

Keyphrases

coronavirus disease
patients with inflammatory bowel disease
sars cov
immune response
single cell
cell therapy
rheumatoid arthritis
respiratory syndrome coronavirus
dendritic cells
binding protein
mesenchymal stem cells